Effectiveness of a Community Health Worker Delivered Care Intervention for Hypertension Control in Uganda (CHW-HTC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05068505 |
Recruitment Status :
Completed
First Posted : October 6, 2021
Last Update Posted : February 29, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hypertension; Community Health Workers | Behavioral: Community health worker delivered multicomponent intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 869 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Participant Recruiters |
Primary Purpose: | Health Services Research |
Official Title: | Effectiveness of a Community Health Worker Delivered Care Intervention for Hypertension Control in Uganda: a Stepped Wedge, Cluster Randomized Control Trial |
Actual Study Start Date : | January 5, 2023 |
Actual Primary Completion Date : | February 1, 2024 |
Actual Study Completion Date : | February 28, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Community health worker delivered multicomponent intervention
The study will employ a closed cohort stepped wedge cluster randomized design. There will be a sequential crossover of clusters from the control to the intervention arms and the order of the cross over will be randomly determined. This study will be conducted in 21 clusters within Nakaseke district. Each cluster will consist of 4-5 villages. We plan to rollout the intervention in three clusters per month.
|
Behavioral: Community health worker delivered multicomponent intervention
The multi-component intervention will be centered on monthly household visits by trained CHWs for a period of seven months in a rural setting in Nakaseke, Uganda, consisting of the following; (1) blood pressure and sugar monitoring; (2) BMI monitoring; (3) cardiovascular disease risk assessment; (4) Using checklists to guide monitoring and referral to clinics; (5) healthy lifestyle counselling and education. During home visits, CHWs will remind patients of follow-up visits. We will measure blood pressure at baseline and 3-monthly for the entire cohort. We will conduct individual-level mixed effects analyses of study data, adjusting for time and clustering by patient and community. We will conduct an interim analysis at 3 months to assess differences between groups. If a statistically significant difference is detected the intervention will be applied across the remaining clusters |
No Intervention: Control
All clusters will be observed under both the intervention and control arm through sequential crossover.
|
- Blood pressure control [ Time Frame: 3 months ]Decrease in the average systolic and/or diastolic blood pressure between the intervention and control arms.
- Glycemic control [ Time Frame: 3 months ]Defined as a reduction >1% in heamoglobin A1C
- Proportion of participants with blood pressure control [ Time Frame: 3 months ]Defined as blood pressure <140/90 mmHg
- Composite negative clinical cardiovascular disease (CVD) outcomes [ Time Frame: 3 months ]Including CVD related admissions, stroke, and myocardial infarction, incident heart failure will be assessed.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Participants with hypertension (Systolic >140 and/or Diastolic >90)
- Participants attending the two NCD clinics
- Adults 18 years and above
- Participants residing in the three sub counties (Nakaseke Town Council, Nakaseke Sub County and Kasangombe of Nakaseke district)
- Participants able to give informed consent.
Exclusion Criteria:
- Patients diagnosed with hypertension but already controlled
- Pregnant women
- Patients with an expected life expectancy of less than one year
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05068505
Uganda | |
Makerere University College of Health Sciences | |
Kampala, Uganda |
Principal Investigator: | Felix Knauf, Prof.Dr.med. | Charité University, Berlin, Germany |
Responsible Party: | Prof. Dr. med. Felix Knauf, Director of the Charité Mitte Campus - Senior Physician, Charite University, Berlin, Germany |
ClinicalTrials.gov Identifier: | NCT05068505 |
Other Study ID Numbers: |
Balamu2021 |
First Posted: | October 6, 2021 Key Record Dates |
Last Update Posted: | February 29, 2024 |
Last Verified: | February 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hypertension Community health workers Uncontrolled blood pressure Uganda |
Hypertension Vascular Diseases Cardiovascular Diseases |